131I-Metaiodobenzylguanidine (MIBG)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 131I-Metaiodobenzylguanidine (MIBG), covering 2018-09-18 to 2018-09-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors [Phase 2]